| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 1023 | 2022 |
| Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 667 | 2021 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 489 | 2022 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... MedRxiv, 2021 | 366 | 2021 |
| Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial O Mosenzon, TM Blicher, S Rosenlund, JW Eriksson, S Heller, OH Hels, ... The lancet Diabetes & endocrinology 7 (7), 515-527, 2019 | 246 | 2019 |
| SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape S Cele, F Karim, G Lustig, JE San, T Hermanus, H Tegally, J Snyman, ... Cell host & microbe 30 (2), 154-162. e5, 2022 | 169 | 2022 |
| Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... Nature communications 13 (1), 4686, 2022 | 147 | 2022 |
| Escape of SARS-CoV-2 501Y S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... V2 variants from neutralization by convalescent plasma. medRxiv 2026 (10 …, 2021 | 128 | 2021 |
| Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection F Karim, MYS Moosa, BI Gosnell, S Cele, J Giandhari, S Pillay, H Tegally, ... MedRxiv, 2021.06. 03.21258228, 2021 | 98 | 2021 |
| Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study EB Wong, S Olivier, R Gunda, O Koole, A Surujdeen, D Gareta, D Munatsi, ... The Lancet Global Health 9 (7), e967-e976, 2021 | 85 | 2021 |
| Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir HS Lo, KPY Hui, HM Lai, X He, KS Khan, S Kaur, J Huang, Z Li, ... ACS central science 7 (5), 792-802, 2021 | 82 | 2021 |
| Omicron sub-lineages BA. 4/BA. 5 escape BA. 1 infection elicited neutralizing immunity K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... MedRxiv, 2022.04. 29.22274477, 2022 | 81 | 2022 |
| Omicron infection enhances Delta antibody immunity in vaccinated persons K Khan, F Karim, S Cele, K Reedoy, JE San, G Lustig, H Tegally, ... Nature 607 (7918), 356-359, 2022 | 70 | 2022 |
| Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung P Ogongo, LB Tezera, A Ardain, S Nhamoyebonde, D Ramsuran, A Singh, ... The Journal of clinical investigation 131 (10), 2021 | 65 | 2021 |
| SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... MedRxiv, 2021.12. 26.21268380, 2021 | 60 | 2021 |
| A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy AJ Greaney, TN Starr, RT Eguia, AN Loes, K Khan, F Karim, S Cele, ... PLoS pathogens 18 (2), e1010248, 2022 | 55 | 2022 |
| Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant K Khan, F Karim, S Cele, JE San, G Lustig, H Tegally, Y Rosenberg, ... Medrxiv, 2022 | 54 | 2022 |
| Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection R Mukherjee, A Bhattacharya, D Bojkova, AR Mehdipour, D Shin, ... Journal of Biological Chemistry 297 (2), 2021 | 53 | 2021 |
| Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Lessells RJ, de Oliveira T, Sigal A. Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 47 | 2021 |
| HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave F Karim, I Gazy, S Cele, Y Zungu, R Krause, M Bernstein, K Khan, ... Elife 10, e67397, 2021 | 46 | 2021 |
Alex SigalAHRIVerified email at AHRI.org
